China National Accord Medicines Corp Ltd Free Cash Flow Generation Index
China National Accord Medicines Corp Ltd free cash flow generation index. China National Accord Medicines Corp Ltd (200028) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of HK$1.78 Billion represents 1% of operating cash flow (HK$1.83 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of China National Accord Medicines Corp Ltd (1998–2025)
Free cash flow generation index of China National Accord Medicines Corp Ltd from 1998 to 2025. Historical FCF Generation Index trend for China National Accord Medicines Corp Ltd across 27 annual periods. See financial flexibility index of China National Accord Medicines Corp Ltd to measure the company's free cash flow as a share of total liabilities.
China National Accord Medicines Corp Ltd Free Cash Flow Generation Index by Year (1998–2025)
China National Accord Medicines Corp Ltd free cash flow generation index by year from 1998 to 2025. Year-by-year Free Cash Flow Generation Index for China National Accord Medicines Corp Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of China National Accord Medicines Corp Ltd.
| Year | FCG Index | Free Cash Flow (HKD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | HK$1.42 Billion | HK$1.64 Billion | HK$217.35 Million | ▼ -5.1% |
| 2024 | 0.91x | HK$2.99 Billion | HK$3.27 Billion | HK$282.70 Million | ▲ +2.6% |
| 2023 | 0.89x | HK$2.61 Billion | HK$2.94 Billion | HK$322.21 Million | ▲ +1.8% |
| 2022 | 0.87x | HK$2.24 Billion | HK$2.56 Billion | HK$322.19 Million | ▲ +12.6% |
| 2021 | 0.78x | HK$1.28 Billion | HK$1.66 Billion | HK$370.43 Million | ▼ -3.5% |
| 2020 | 0.80x | HK$1.21 Billion | HK$1.50 Billion | HK$293.83 Million | ▼ -8.3% |
| 2019 | 0.88x | HK$1.76 Billion | HK$2.00 Billion | HK$245.17 Million | ▲ +8.8% |
| 2018 | 0.81x | HK$1.07 Billion | HK$1.32 Billion | HK$255.48 Million | ▼ -4.1% |
| 2017 | 0.84x | HK$1.08 Billion | HK$1.29 Billion | HK$204.35 Million | ▲ +2.6% |
| 2016 | 0.82x | HK$1.21 Billion | HK$1.47 Billion | HK$265.89 Million | ▲ +0.1% |
| 2015 | 0.82x | HK$857.62 Million | HK$1.05 Billion | HK$190.36 Million | ▲ +21.0% |
| 2013 | 0.68x | HK$314.53 Million | HK$465.03 Million | HK$150.50 Million | ▲ +68.1% |
| 2012 | 0.40x | HK$130.38 Million | HK$323.96 Million | HK$193.57 Million | ▲ +222.8% |
| 2011 | 0.12x | HK$28.35 Million | HK$227.32 Million | HK$198.97 Million | ▼ -78.7% |
| 2010 | 0.58x | HK$250.17 Million | HK$428.16 Million | HK$177.99 Million | ▼ -5.8% |
| 2009 | 0.62x | HK$167.91 Million | HK$270.85 Million | HK$102.94 Million | ▼ -5.4% |
| 2008 | 0.66x | HK$161.60 Million | HK$246.58 Million | HK$84.98 Million | ▲ +252.9% |
| 2007 | 0.19x | HK$16.29 Million | HK$87.70 Million | HK$71.41 Million | ▼ -46.9% |
| 2006 | 0.35x | HK$63.51 Million | HK$181.73 Million | HK$118.22 Million | ▼ -46.9% |
| 2005 | 0.66x | HK$97.65 Million | HK$148.28 Million | HK$50.62 Million | ▼ -26.1% |
| 2004 | 0.89x | HK$116.11 Million | HK$130.30 Million | HK$14.18 Million | ▲ +127.2% |
| 2003 | 0.39x | HK$31.86 Million | HK$81.22 Million | HK$49.36 Million | ▲ +504.3% |
| 2002 | 0.06x | HK$1.87 Million | HK$28.76 Million | HK$26.90 Million | ▼ -86.9% |
| 2001 | 0.50x | HK$35.25 Million | HK$71.16 Million | HK$35.91 Million | ▲ +133.8% |
| 2000 | -1.47x | HK$-12.49 Million | HK$8.52 Million | HK$21.01 Million | ▼ -612.6% |
| 1999 | -0.21x | HK$-4.70 Million | HK$22.84 Million | HK$27.54 Million | ▲ +79.3% |
| 1998 | -0.99x | HK$-5.17 Million | HK$5.21 Million | HK$10.38 Million | — |